Jynarque
Ended Awarded Last action
- Contract number
- 36C26124N0402
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $100,646
Award facts
- Contract value 100% obligated
- $100,645.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$12,581 | |
| Original award | $113,226 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $100,645.76 delivery order to Otsuka America Pharmaceutical Inc. on January 24, 2024, for the supply of Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm fixed-price delivery order, with an ultimate completion date of March 25, 2024, does not utilize any set-aside designation and is performed at a location in Potomac, Maryland. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), through which Otsuka America maintains established contracting vehicles with the VA.
This delivery order is issued under a larger $83.3 million Blanket Purchase Agreement for Jynarque that Otsuka America holds with the VA's National Acquisition Center, which provides VA facilities across multiple Integrated Service Networks with streamlined procurement authority for this critical medication. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is an established federal contractor and for-profit pharmaceutical manufacturer specializing in complex medical condition treatments. The company's significant federal supply schedule contracts, including a $396 million agreement for pharmaceuticals and hematology-related products, demonstrate its capability to serve as a reliable supplier to the VA's healthcare system supporting veterans nationwide.
Quick answers
Who was awarded contract 36C26124N0402?
36C26124N0402 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on January 24, 2024.
How much is contract 36C26124N0402 worth?
The government has obligated $100,646 on 36C26124N0402.
Is contract 36C26124N0402 an order under another contract?
Yes. 36C26124N0402 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0402 competed?
The extent of competition for 36C26124N0402 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award